Overview
Tempus AI sells genomic and diagnostic tests to clinicians and licenses de-identified clinical and molecular data to pharmaceutical companies, using machine-learning models to match patients to therapies and trials. Revenue in 2025 was US$1.27 billion[11]. The company was founded in 2015, renamed Tempus Labs in 2016 and Tempus AI in 2023, and reincorporated from Delaware to Nevada on 7 August 2025; its principal executive offices are in Chicago[11]. Its revenue therefore comes mostly from laboratory testing and data licensing rather than from software subscriptions, which places it at the applied end of the AI industry. The 10-K highlights its limited operating history and rapid growth as factors that make its prospects difficult to evaluate[11].
Appears in
Tempus AI alternatives and competitors
Alternatives to Tempus AI: companies ranked in the same lists.
- NVIDIA
Scale AI
WhiteFiber- MiniMax
- Recursion Pharmaceuticals
Rezolve AI
Nscale
Kodiak AI
Aurora Innovation
Figure AI
Crusoe
Mistral AI
Is this your company?
Update the description, logo, image and link through the submission form. Editors review every change.